U.S.
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON,
D.C. 20549



FORM
10-Q



[x]	QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For
the quarterly period ended:  June 30, 2011



OR



[
]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For
the transition period from  ___ to ____



Commission
File Number 000-31012



GLOBAL
HEALTH VOYAGER, INC.



(Exact
name of registrant as specified in its charter)



|Delaware                                                                                                                       |  | 94-3357128                              
|------------------------------------------------------------------------------------------------------------------------------ |  | ----------------------------------------
|(State or other
    jurisdiction of incorporation or organization)                                                             |  | (I.R.S. Employer
    Identification No.)
|                                                                                                                               |  |                                         
|7800
                                                                    Oceanus Drive
        Los
        Angeles, California |  | 90046                                   
|(Address of principal
    executive offices)                                                                                   |  | (Zip Code)                              



Registrant's
telephone number: (323) 445-4833



NT
MEDIA CORP. OF CALIFORNIA, INC.



(Former
Name, former address and former fiscal year, if changed since last report)



Indicate
by check mark whether the registrant  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]



Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if  any,
every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding
12 months (or for such shorter period that the registrant was required to submit and post such files).
 Yes [ ] No [ ]

Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of "large accelerated filer," ”accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act.



|Large
    accelerated filer [ ]                                             | Accelerated
    filer [ ]        
|--------------------------------------------------------------------------- | ---------------------------------
|Non-accelerated
    filer [ ] (Do not check if a smaller reporting company) | Smaller reporting
    company [x]



Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes[  ] No [ x]



Number
of shares outstanding as of August 15, 2011: 26,842,093 common shares.



1









GLOBAL
HEALTH VOYAGER, INC. AND SUBSIDIARIES

June
30, 2011 (unaudited)



INDEX



|           |                       |                                                                                       | Page
    No.
|---------- | --------------------- | ------------------------------------------------------------------------------------- | ------------
|PART I.    | Financial Information | 3                                                                                    
|           |                       |                                                                                      
|           | Item 1.               | Consolidated Financial Statements                                                     | 3           
|           |                       |                                                                                       |             
|           |                       | Notes to Consolidated Financial Statements                                            | 7           
|           |                       |                                                                                       |             
|           | Item 2.               | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 14          
|           |                       |                                                                                       |             
|           | Item 3.               | Quantitative and Qualitative Disclosures About Market Risk                            | 18          
|           |                       |                                                                                       |             
|           | Item 4.               | Controls and Procedures                                                               | 18          
|           |                       |                                                                                       |             
|PART II.   | Other Information     | 19                                                                                   
|           |                       |                                                                                      
|           | Item 1.               | Legal Proceedings                                                                     | 19          
|           |                       |                                                                                       |             
|           | Item 1A               | Risk Factors                                                                          | 19          
|           |                       |                                                                                       |             
|           | Item 2.               | Unregistered Sales of Equity Securities and Use of Proceeds                           | 19          
|           |                       |                                                                                       |             
|           | Item 3.               | Defaults Upon Senior Securities                                                       | 20          
|           |                       |                                                                                       |             
|           | Item 4.               | Removed and Reserved                                                                  | 20          
|           |                       |                                                                                       |             
|           | Item 5.               | Other Information                                                                     | 20          
|           |                       |                                                                                       |             
|           | Item 6.               | Exhibits                                                                              | 20          
|           |                       |                                                                                       |             
|SIGNATURES |                       | 21                                                                                   





2







PART I

FINANCIAL INFORMATION



ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS



Global Health Voyager, Inc.
and Subsidiaries

(A Development Stage Company)

Consolidated Balance Sheets







|                                                                                                                          |  |  
|------------------------------------------------------------------------------------------------------------------------- |  | -
|                                                                                                                          |  |  
|                                                                                                                          |  |  
|ASSETS                                                                                                                    |  |  
|                                                                                                                          |  |  
|CURRENT ASSETS                                                                                                            |  |  
|Cash and equivalents                                                                                                      |  | $
|Prepaid Expenses                                                                                                          |  |  
|                                                                                                                          |  |  
|TOTAL CURRENT ASSETS                                                                                                      |  | $
|                                                                                                                          |  |  
|                                                                                                                          |  |  
|LIABILITIES AND STOCKHOLDERS' DEFICIT                                                                                     |  |  
|                                                                                                                          |  |  
|CURRENT LIABILITIES                                                                                                       |  |  
|Accounts payable                                                                                                          |  | $
|Accrued liabilities                                                                                                       |  |  
|Accrued liabilities to related parties                                                                                    |  |  
|Notes payable                                                                                                             |  |  
|Notes payable, related party                                                                                              |  |  
|Convertible notes payable                                                                                                 |  |  
|Convertible notes payable, related party                                                                                  |  |  
|Accrued litigation settlement                                                                                             |  |  
|                                                                                                                          |  |  
|TOTAL CURRENT LIABILITIES                                                                                                 |  |  
|                                                                                                                          |  |  
|LONG TERM LIABILITIES                                                                                                     |  |  
|Convertible notes payable                                                                                                 |  |  
|                                                                                                                          |  |  
|TOTAL LIABILITIES                                                                                                         |  |  
|                                                                                                                          |  |  
|COMMITMENTS AND CONTINGENCIES                                                                                             |  |  
|                                                                                                                          |  |  
|STOCKHOLDERS' DEFICIT                                                                                                     |  |  
|Preferred stock, $0.001 par value, 5,000,000 shares                                                                       |  |  
|authorized; 0 shares issued and outstanding                                                                               |  |  
|Common stock; $0.001 par value; 1,000,000,000 shares                                                                      |  |  
|authorized; 26,842,093 and 26,542,093  shares issued and outstanding and June 30, 2011 and December 31, 2010 respectively |  |  
|Additional paid-in capital                                                                                                |  |  
|Deficit accumulated during the development stage                                                                          |  |  
|                                                                                                                          |  |  
|TOTAL STOCKHOLDERS' DEFICIT                                                                                               |  |  
|                                                                                                                          |  |  
|TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                                                                               |  | $
|                                                                                                                         
|See accompanying notes to consolidated financial statements.                                                             









3









Global Health Voyager, Inc.
and Subsidiaries

(A Development Stage Company)

Consolidated Statements of
Operations

(UNAUDITED)







|                                                             |  |   | Three
                                                                            Months Ended |  
|------------------------------------------------------------ |  | - | ---------------------------------------------------------------------------------------------- | -
|                                                             |  |   | June
                                                                            30,           |  
|                                                             |  |   | 2011                                                                                           |  
|REVENUES                                                     |  | $ | —                                                                                              |  
|                                                             |  |   |                                                                                                |  
|COSTS AND EXPENSES                                           |  |   |                                                                                                |  
|General and administrative                                   |  |   | 130,189                                                                                        |  
|TOTAL COSTS AND EXPENSES                                     |  |   | 130,189                                                                                        |  
|                                                             |  |   |                                                                                                |  
|LOSS FROM OPERATIONS                                         |  |   | (130,189                                                                                       | )
|                                                             |  |   |                                                                                                |  
|OTHER EXPENSE                                                |  |   |                                                                                                |  
|Interest expense                                             |  |   | (38,359                                                                                        | )
|Interest expense, related party                              |  |   | (12,681                                                                                        | )
|TOTAL OTHER EXPENSE                                          |  |   | (51,040                                                                                        | )
|                                                             |  |   |                                                                                                |  
|NET LOSS ATTRIBUTABLE TO GLOBAL HEALTH                       |  |   |                                                                                                |  
|VOYAGER, INC.  AND SUBSIDIARIES                              |  | $ | (181,229                                                                                       | )
|                                                             |  |   |                                                                                                |  
|NET (LOSS) PER SHARE:                                        |  |   |                                                                                                |  
|BASIC AND DILUTED                                            |  | $ | (0.0068                                                                                        | )
|                                                             |  |   |                                                                                                |  
|WEIGHTED AVERAGE SHARES OUTSTANDING:                         |  |   |                                                                                                |  
|BASIC AND DILUTED                                            |  |   | 26,601,434                                                                                     |  
|                                                             |  |   |                                                                                                |  
|                                                             |  |   |                                                                                                |  
|                                                            
|See accompanying notes to consolidated financial statements.







4









Global Health Voyager, Inc.
and Subsidiaries

(A Development Stage Company)

Consolidated Statements of
Operations

(unaudited)





|                                                             |  |   |                                                                                        |   |  |  
|------------------------------------------------------------ |  | - | -------------------------------------------------------------------------------------- | - |  | -
|                                                             |  |   |                                                                                        |   |  |  
|                                                             |  |   | Six
                                                                      Months Ended |   |  |  
|                                                             |  |   | June
                                                                      30,         |   |  |  
|                                                             |  |   | 2011                                                                                   |   |  |  
|REVENUES                                                     |  | $ | —                                                                                      |   |  | $
|                                                             |  |   |                                                                                        |   |  |  
|COSTS AND EXPENSES                                           |  |   |                                                                                        |   |  |  
|General and administrative                                   |  |   | 225,518                                                                                |   |  |  
|Depreciation and amortization                                |  |   | —                                                                                      |   |  |  
|Impairment of film costs                                     |  |   | —                                                                                      |   |  |  
|Impairment of related party receivables                      |  |   | —                                                                                      |   |  |  
|Inventory write-down                                         |  |   | —                                                                                      |   |  |  
|Loss on litigation settlement                                |  |   | —                                                                                      |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|TOTAL COSTS AND EXPENSES                                     |  |   | 225,518                                                                                |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|LOSS FROM OPERATIONS                                         |  |   | (225,518                                                                               | ) |  |  
|                                                             |  |   |                                                                                        |   |  |  
|OTHER INCOME (EXPENSE)                                       |  |   |                                                                                        |   |  |  
|Interest income, related party                               |  |   | —                                                                                      |   |  |  
|Interest expense                                             |  |   | (73,782                                                                                | ) |  |  
|Interest expense, related party                              |  |   | (24,190                                                                                | ) |  |  
|Loan fees                                                    |  |   | —                                                                                      |   |  |  
|Debt forgiven                                                |  |   | —                                                                                      |   |  |  
|Legal fees forgiven                                          |  |   | —                                                                                      |   |  |  
|Provision for common stock subscription receivable           |  |   | —                                                                                      |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|TOTAL OTHER INCOME (EXPENSE)                                 |  |   | (97,972                                                                                | ) |  |  
|                                                             |  |   |                                                                                        |   |  |  
|LOSS BEFORE PROVISION FOR INCOME TAXES                       |  |   | (323,490                                                                               | ) |  |  
|AND NONCONTROLLING INTEREST                                  |  |   |                                                                                        |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|PROVISION FOR INCOME TAXES                                   |  |   | 800                                                                                    |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|LOSS BEFORE NON-CONTROLLING INTEREST                         |  |   | (324,290                                                                               | ) |  |  
|                                                             |  |   |                                                                                        |   |  |  
|LESS: LOSS ATTRIBUTABLE TO NON-CONTROLLING                   |  |   |                                                                                        |   |  |  
|INTEREST                                                     |  |   | —                                                                                      |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|NET LOSS ATTRIBUTABLE TO GLOBAL HEALTH                       |  |   |                                                                                        |   |  |  
|VOYAGER, INC. AND SUBSIDIARIES                               |  | $ | (324,290                                                                               | ) |  | $
|                                                             |  |   |                                                                                        |   |  |  
|NET (LOSS) PER SHARE:                                        |  |   |                                                                                        |   |  |  
|BASIC AND DILUTED                                            |  | $ | (0.012                                                                                 | ) |  | $
|                                                             |  |   |                                                                                        |   |  |  
|WEIGHTED AVERAGE SHARES OUTSTANDING:                         |  |   |                                                                                        |   |  |  
|BASIC AND DILUTED                                            |  |   | 26,571,927                                                                             |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|                                                            
|See accompanying notes to consolidated financial statements.







5







Global Health Voyager, Inc.
and Subsidiaries

(A Development Stage Company)

Consolidated Statements of
Cash Flows

(unaudited)







|                                                             |  |   |                                                                                        |   |  |  
|------------------------------------------------------------ |  | - | -------------------------------------------------------------------------------------- | - |  | -
|                                                             |  |   |                                                                                        |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|                                                             |  |   | Six
                                                                      Months Ended |   |  |  
|                                                             |  |   | June
                                                                      30,         |   |  |  
|                                                             |  |   | 2011                                                                                   |   |  |  
|CASH FLOWS FROM OPERATING ACTIVITIES:                        |  |   |                                                                                        |   |  |  
|Net loss before non-controlling interest                     |  | $ | (324,290                                                                               | ) |  | $
|Adjustments to reconcile net loss to net cash                |  |   |                                                                                        |   |  |  
|used in operating activities:                                |  |   |                                                                                        |   |  |  
|Depreciation and amortization                                |  |   | —                                                                                      |   |  |  
|Impairment loss                                              |  |   | —                                                                                      |   |  |  
|Inventory write-down                                         |  |   | —                                                                                      |   |  |  
|Impairment of related party receivables                      |  |   | —                                                                                      |   |  |  
|Operating expenses paid by reducing note receivable          |  |   | —                                                                                      |   |  |  
|Stock issued for services                                    |  |   | 13,500                                                                                 |   |  |  
|Deferred compensation                                        |  |   | —                                                                                      |   |  |  
|Stock issued for loan fees                                   |  |   | —                                                                                      |   |  |  
|Stock options issued for services                            |  |   | —                                                                                      |   |  |  
|Legal fees forgiven                                          |  |   | —                                                                                      |   |  |  
|Debts forgiven                                               |  |   | —                                                                                      |   |  |  
|Provision for common stock subscription receivable           |  |   | —                                                                                      |   |  |  
|Amount attributable to non-controlling interest              |  |   | —                                                                                      |   |  |  
|Beneficial conversion of debt and accrued interest           |  |   | —                                                                                      |   |  |  
|Changes in assets and liabilities:                           |  |   |                                                                                        |   |  |  
|Interest receivable                                          |  |   | —                                                                                      |   |  |  
|Inventory                                                    |  |   | —                                                                                      |   |  |  
|Prepaid Expenses                                             |  |   | (6,271                                                                                 | ) |  |  
|Other assets                                                 |  |   | —                                                                                      |   |  |  
|Litigation settlement                                        |  |   | —                                                                                      |   |  |  
|Accounts payable and accrued expenses                        |  |   | 107,799                                                                                |   |  |  
|Accrued expenses, related party                              |  |   | 99,190                                                                                 |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|Net cash (used in) operating activities                      |  |   | (110,072                                                                               | ) |  |  
|                                                             |  |   |                                                                                        |   |  |  
|CASH FLOWS FROM INVESTING ACTIVITIES:                        |  |   |                                                                                        |   |  |  
|Notes receivable from officer                                |  |   | —                                                                                      |   |  |  
|Collection of notes receivable from officer                  |  |   | —                                                                                      |   |  |  
|Notes receivable, related parties                            |  |   | —                                                                                      |   |  |  
|Collection of notes receivable, related parties              |  |   | —                                                                                      |   |  |  
|Investment in property and equipment                         |  |   | —                                                                                      |   |  |  
|Investment in film costs                                     |  |   | —                                                                                      |   |  |  
|Investment in web site development costs                     |  |   | —                                                                                      |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|Net cash (used in) investing activities                      |  |   | —                                                                                      |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|CASH FLOWS FROM FINANCING ACTIVITIES:                        |  |   |                                                                                        |   |  |  
|Proceeds from issuance of common stock                       |  |   | —                                                                                      |   |  |  
|Payment of offering costs                                    |  |   | —                                                                                      |   |  |  
|Proceeds from notes payable                                  |  |   | 50,000                                                                                 |   |  |  
|Proceeds from notes payable, related party                   |  |   | 36,012                                                                                 |   |  |  
|Payments of notes payable                                    |  |   | —                                                                                      |   |  |  
|Payments of notes payable, related party                     |  |   | —                                                                                      |   |  |  
|Proceeds from issuance of convertible notes                  |  |   | 350,000                                                                                |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|Net cash provided by financing activities                    |  |   | 436,012                                                                                |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|NET INCREASE (DECREASE) IN CASH AND                          |  |   |                                                                                        |   |  |  
|EQUIVALENTS                                                  |  |   | 325,940                                                                                |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|CASH AND EQUIVALENTS,                                        |  |   |                                                                                        |   |  |  
|Beginning of period                                          |  |   | 1                                                                                      |   |  |  
|CASH AND EQUIVALENTS,                                        |  |   |                                                                                        |   |  |  
|End of period                                                |  | $ | 325,941                                                                                |   |  | $
|                                                             |  |   |                                                                                        |   |  |  
|SUPPLEMENTAL DISCLOSURES OF                                  |  |   |                                                                                        |   |  |  
|CASH FLOW INFORMATION:                                       |  |   |                                                                                        |   |  |  
|Cash paid during the period for:                             |  |   |                                                                                        |   |  |  
|Interest paid                                                |  | $ | —                                                                                      |   |  | $
|Income taxes paid                                            |  | $ | —                                                                                      |   |  | $
|                                                             |  |   |                                                                                        |   |  |  
|NONCASH FINANCING ACTIVITIES:                                |  |   |                                                                                        |   |  |  
|Beneficial conversion of debt and accrued interest           |  | $ | —                                                                                      |   |  | $
|Stock issued for services                                    |  | $ | 13,500                                                                                 |   |  | $
|Stock issued for loan fees                                   |  | $ | —                                                                                      |   |  | $
|Stock options issued for services                            |  | $ | —                                                                                      |   |  | $
|                                                             |  |   |                                                                                        |   |  |  
|                                                             |  |   |                                                                                        |   |  |  
|See accompanying notes to consolidated financial statements.





6









GLOBAL
HEALTH VOYAGER, INC. AND SUBSIDIARIES

(A
DEVELOPMENT STAGE COMPANY)

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010 (unaudited) and December 31, 2010











NOTE 1.  BASIS
OF PRESENTATION



The
unaudited consolidated financial statements were prepared by Global Health Voyager, Inc., its wholly owned subsidiary, eCast Media
Corporation, Inc., and 51% owned subsidiary SU Distribution, LLC (together, the "Company"), in accordance with generally
accepted accounting principles for interim financial information and with the instructions for Quarterly Reports on Form 10-Q
and Regulation S-X as promulgated by the Securities and Exchange Commission ("SEC"). Accordingly, these consolidated
financial statements do not include all disclosures required by generally accepted accounting principles in the US ("US GAAP")
for complete financial statements. These unaudited interim consolidated financial statements should be read in conjunction with
the audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K
for the period ended December 31, 2010. In the opinion of management, the unaudited interim consolidated financial statements
furnished herein include all adjustments, all of which are of a normal recurring nature, necessary for a fair statement of the
results for the interim period presented. The results of the six months ended June 30, 2011 are not necessarily indicative of
the results to be expected for the full year ending December 31, 2011.



NOTE
2. GOING CONCERN AND MANAGEMENT'S PLANS



The
accompanying consolidated financial statements were prepared in conformity with US GAAP, which contemplates continuation of the
Company as a going concern. As of and for the six months ended June 30, 2011, the Company incurred a net loss and had accumulated
and working capital deficits. These conditions raise substantial doubt as to the Company's ability to continue as a going concern.
These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.  These
unaudited consolidated financial statements do not include any adjustments relating to the recoverability and classification of
recorded asset amounts, or amounts and classification of liabilities that might be necessary should the Company be unable to continue
as a going concern.



In
order for the Company to meet its financial obligations, it will continue to attempt to sell equity or incur debt, although there
cannot be any assurance that the Company will be successful in doing so.



The
Company plans to take advantage of the growth in the medical tourism industry as a facilitator through joint ventures, partnerships,
and agreements. The Company intends to enter into agreements with hospitals, insurance companies, travel agencies, facilitators,
and other healthcare providers to establish a creditable network and effectively obtain a strong market presence within the medical
tourism industry. The Company will attempt to enter into partnership agreements with other entities in order to manage some of
the financial risk. The Company's ability to develop these relationships is principally dependent on its ability to raise capital
to fund the project, which is very difficult due to its current financial condition and lack of history in the market.



The
Company's current business operations are focused on facilitating medical procedures in the medical tourism industry, including
creating a web-based platform, building relations with hospitals and healthcare providers both in the US and abroad, and vertical
social and professional networks.



The
Company’s strategy is to obtain market share within the medical tourism industry by building a web-based platform that would
enhance its web presence and market the Company as a one-stop-shop for medical tourism needs. The Company plans to attend various
industry conferences and trade shows to build relationships and partnerships within the healthcare industry that would further
enhance the Company’s position within the medical tourism industry.





7







GLOBAL
HEALTH VOYAGER, INC. AND SUBSIDIARIES

(A
DEVELOPMENT STAGE COMPANY)

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

June
30, 2011 and 2010 (unaudited) and December 31, 2010









NOTE
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES



Basis
of Presentation



Because
the Company has not generated any significant revenue, it is considered a development stage company. Consequently, the accompanying
consolidated financial statements were prepared using the accounting formats prescribed for development stage enterprises in accordance
with ASC 915, “Development Stage Entities”. The Company’s year end is December 31st.



Basis
of Consolidation



The
consolidated financial statements include the accounts of Global Health Voyager, Inc. and its wholly owned subsidiary, eCast,
and its 51% owned subsidiary, SUD. eCast and SUD are inactive. All significant intercompany accounts and transactions were eliminated
in consolidation.



Cash
and Equivalents



Cash
and equivalents consist primarily of cash on deposit with original maturities of three months or less.



Use
of Estimates



The
preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions
that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities and the reported
amounts of revenues and expenses. Actual results could differ from those estimates.



Reclassifications



Certain
prior period amounts were reclassified to conform to current period presentation, none of which changed total assets, stockholders'
deficit, net loss, or net loss per share.



Equipment
and Depreciation



Equipment
is recorded at cost. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and
repairs expensed as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed
from the accounts and any reselling gain or loss is included in the results of operations for the respective period. Depreciation
is provided over the estimated useful lives of the related assets using the straight-line method for consolidated financial statements
purposes. There was no depreciation expense recorded for the six months ended June 30, 2011 or 2010.



Fair
Value of Financial Instruments



The
carrying value of cash, deferred revenue, accounts payable, and accrued expenses approximate fair value because of the short maturity
of these items.



Revenue
Recognition



Revenues
are recognized on an accrual basis. Generally, revenues will be recognized when persuasive evidence of an arrangement exists,
services have been rendered, the price is fixed and determinable, and collectability is reasonably assured.



Concentrations
of Credit Risk



The
Company maintains all cash in bank accounts, which at times may exceed federally insured limits. The Company has not experienced
a loss in such accounts.

Income
Taxes





8









GLOBAL
HEALTH VOYAGER, INC. AND SUBSIDIARIES

(A
DEVELOPMENT STAGE COMPANY)

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

June
30, 2011 and 2010 (unaudited) and December 31, 2010









The
Company follows the liability method of accounting for income taxes pursuant to ASC 740, “Accounting for Income Taxes”.
Under ASC 740 deferred income taxes are recorded to reflect tax consequences on future years for the differences between the tax
bases of assets and liabilities and their financial reporting amounts at each year-end.



Deferred
tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements
carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and
credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in
which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of
a change in tax rates is recognized in income in the period that includes the enactment date.



The
components of the deferred tax assets and liabilities are individually classified as current and non-current based on their characteristics.
Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some
portion or all of the deferred tax assets will not be realized.



The
Company follows ASC 740-10, “Accounting for Uncertainty in Income Taxes”. As a result, the Company applies a more-likely-than-not
recognition threshold for all tax uncertainties. ASC 740-10 only allows the recognition of those tax benefits that have a greater
than fifty percent likelihood of being sustained upon examination by the taxing authorities. As a result of implementing ASC 740-10,
the Company’s management reviewed the Company’s tax positions and determined there were no outstanding, or retroactive
tax positions with less than a 50% likelihood of being sustained upon examination by the taxing authorities, therefore the implementation
of this standard has not had a material affect on the Company.



Based
on its evaluation, the Company concluded there were no significant uncertain tax positions requiring recognition in its financial
statements as of June 30, 2011 and December 31, 2010.



The
Company does not have any unrecognized tax benefits as of June 30, 2011 and 2010 which if recognized would affect the Company’s
effective income tax rate.



The
Company’s policy is to recognize interest and penalties related to income tax issues as components of income tax expense.
The Company did not recognize or incur any accrual for interest and penalties relating to income taxes during the six months ended
June 30, 2011 and 2010.



California
law requires payments of a minimum franchise tax of $800 by corporations that are qualified to do business in California. The
Company has not paid the $800 minimum tax for 2011 and 2010, nor has it filed its tax returns, causing the California Secretary
of State to forfeit its corporate status. The Company is in the process of filing all delinquent corporate tax returns in order
to re-establish its corporate status.



Impairment
of Long-Lived Assets



The
Company adopted ASC 360, "Accounting for the Impairment or Disposal of Long-Lived Assets". The Company evaluates its
long-lived assets by measuring the carrying amounts of assets against the estimated undiscounted future cash flows associated
with them. At the time the carrying value of such assets exceeds the fair value of such assets, impairment is recognized.



Advertising
Costs



Advertising
and sales promotion costs are expensed as incurred. The Company did not incur any advertising costs for the six months ended June
30, 2011 and 2010.





9







GLOBAL
HEALTH VOYAGER, INC. AND SUBSIDIARIES(A DEVELOPMENT STAGE COMPANY)NOTES TO CONSOLIDATED FINANCIAL STATEMENTSJune 30, 2011 and 2010 (unaudited) and December 31, 2010





Loss
per Common Share



The
Company computes loss per common share in accordance with ASC 260-10-45, "Earnings per Share". The Statement
requires dual presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital
structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and
denominator of the diluted EPS computation. Basic loss per share is computed by dividing loss available to common
shareholders by the weighted average number of common shares outstanding. The computation of diluted loss per share is
similar to the basic loss per share computation except the denominator is increased to include the number of additional
shares that would have been outstanding if the dilutive potential common shares had been issued. In addition, the numerator
is adjusted for any changes in income or loss that would result from the assumed conversions of those potential shares.
Accordingly, the diluted per share amounts do not reflect the impact of warrants and options outstanding, for 1,750,000 and
-0- shares at June 30, 2011 or December 31, 2010 respectively, because the effect of each is antidilutive. Basic loss per
share for the six months and three months ended June 30, 2011 and 2010 were as follows:





|                                 |       |         |        
|-------------------------------- | ----- | ------- | -------
|                                 | Basic |         | Diluted
|Six Months Ended June 30, 2011   |       | (0.0120 | )      
|Six Months Ended June 30, 2010   |       | (0.0150 | )      
|Three Months Ended June 30, 2011 |       | (0.0068 | )      
|Three Months Ended June 30, 2010 |       | (0.0098 | )      
|                                 |       |         |        







Stock
Based Compensation to Other than Employees



The
Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance
with ASC 718 (previously Statement of Financial Accounting Standards No. 123), “Accountingfor Stock-Based Compensation,”
and the conclusions reached by the ASC 505-50 (previously Emerging Issues Task Force in Issue No. 96- 18), “Accounting for
Equity Instruments That Are Issued to Other Than Employees for Acquiring or in Conjunction with Selling Goods or Services”
(“ASC 505-50”). Costs are measured at the estimated fair market value of the consideration received or the estimated
fair value of the equity instruments issued, whichever is more reliably determinable. The value of equity instruments issued for
consideration other than employee services is determined on the earlier of a performance commitment or completion of performance
by the provider of goods or services as defined by ASC 505-50 (previously EITF 96-18). In the case of equity instruments issued
to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement.



NOTE
4. RECENTLY ISSUED ACCOUNTING STANDARDS



The
Company has adopted all accounting pronouncements effective before June 30, 2011, which are applicable to the Company.



NOTE
5.NOTES PAYABLE



During
the quarter ended June 30, 2011, the Company issued two promissory notes, $20,000 each, bearing interest at 12% and 15%, respectively,
due July 2011. No payments have been made on these notes. They were verbally extended and not considered in default.



During
the quarter ended March 31, 2011, the Company issued a promissory note of $10,000 bearing interest at 12% due June 2011. No payments
have been made on this note. It was verbally extended and not considered in default.



At June
30, 2011 and December 31, 2010, notes payable to non-related parties consisted of the following:





10









GLOBAL
HEALTH VOYAGER, INC. AND SUBSIDIARIES

(A
DEVELOPMENT STAGE COMPANY)

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010 (unaudited) and
December 31, 2010









|                                                             |  |   |                                                                                           | 
|------------------------------------------------------------ |  | - | ----------------------------------------------------------------------------------------- | 
|                                                             |  |   | June
                                                                            30, 2011 | 
|Notes payable bearing interest at 12%, due through July 2011 |  | $ | 922,621                                                                                   | 
|Note payable bearing interest at 15%, due July 2011          |  |   | 20,000                                                                                    | 
|Notes payable bearing interest at 10%, due on demand         |  |   | 128,000                                                                                   | 
|Notes payable bearing interest at 12.5% due on demand        |  |   | 38,750                                                                                    | 
|                                                             |  |   |                                                                                           | 
|Total Due                                                    |  | $ | 1,109,371                                                                                 | 
|                                                             |  |   |                                                                                           | 









Interest
expense for the six months ended June 30, 2011 and 2010 was $63,238 and $53,775, respectively. Interest expense for the three
months ended June 30, 2011 and 2010 was $ 32,048 and $ 28,191, respectively.



NOTE
6. NOTES PAYABLE – RELATED PARTIES



During
the quarter ended June 30, 2011, the Company issued notes of $10,117 to its President at 12% due at various dates through July
2011. No payments have been made. The notes have been verbally extended and are not considered in default.



During
the quarter ended March 31, 2011, the Company issued notes of $8,760 to its President at 12% due at various dates through June
2011.  No payments have been made. The notes have been verbally extended and are not considered in default.



During
the quarter ended March 31, 2011, the Company issued notes of $17,135 to a related party at 12% due at various dates through June
2011. No payments have been made. The notes have been verbally extended and are not considered in default.





At
June 30, 2011 and December 31, 2010, notes payable, all currently due, to related parties consisted of the following:





|                                                      |  |   |               | 
|----------------------------------------------------- |  | - | ------------- | 
|                                                      |  |   | June 30, 2011 | 
|                                                      |  |   |               | 
|Note payable, interest at 15%, due on demand          |  | $ | 1,170         | 
|Notes payable, interest at 12%, due through July 2011 |  |   | 10,117        | 
|Notes payable, interest at 12%, due on demand         |  |   | 60,569        | 
|Non-interest bearing notes due on demand              |  |   | 1,372         | 
|Non-interest bearing due on demand                    |  |   | 6,000         | 
|                                                      |  | $ | 79,228        | 
|                                                      |  |   |               | 



Interest
expense for the six months ended June 30, 2011 and 2010 was $ 5,422 and $ 677, respectively. Interest expense for the three months
ended June 30, 2011 and 2010 was $ 3,297 and $ -0-, respectively.



NOTE
7. CONVERTIBLE NOTES PAYABLE



During
the quarter ended June 30, 2011, the Company issued $350,000 in convertible notes payable, bearing interest at 10%, due June 2014.
All notes are convertible to common shares, $0.001 par value, at the lower of $0.10 or 80% of the average closing bid during the
five days immediately prior to the conversion date. The Company also issued warrants to purchase up to 1,750,000 shares of common
stock for $0.10 as part of the convertible note issuance. The value attributed to the warrants was $16,110, treated as additional
paid-in capital.





11









GLOBAL
HEALTH VOYAGER, INC. AND SUBSIDIARIES

(A
DEVELOPMENT STAGE COMPANY)

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTSJune 30, 2011 and 2010 (unaudited) and December
31, 2010









At
June 30, 2011 and December 31, 2010, convertible notes payable to non-related parties consisted of the following:



|                                                                |  |   |               |   |  |   |                   |  
|--------------------------------------------------------------- |  | - | ------------- | - |  | - | ----------------- | -
|                                                                |  |   | June 30, 2011 |   |  |   | December 31, 2010 |  
|Convertible notes payable bearing interest at 6%, due on demand |  | $ | 282,200       |   |  | $ | 282,200           |  
|Notes payable bearing interest at 10% due July 2014             |  |   | 350,000       |   |  |   | —                 |  
|                                                                |  |   |               |   |  |   |                   |  
|Total Due                                                       |  | $ | 632,200       |   |  | $ | 282,200           |  
|Less: Current portion                                           |  |   | (282,200      | ) |  |   | (282,200          | )
|Less: Amount attributable to warrants issued with debt          |  |   | (16,110       | ) |  |   | —                 |  
|Convertible notes payable                                       |  | $ | 333,890       |   |  | $ | —                 |  







Interest expense
for the six months ended June 30, 2011 and 2010 was $10,544 and $8,466, respectively. Interest expense for the three months ended
June 30, 2011 and 2010 was $6,311 and $4,232 respectively.



NOTE
8. CONVERTIBLE NOTES PAYABLE – RELATED PARTIES



At
June 30, 2011, convertible notes payable to related parties, bearing interest at 6%, totaled $625,600 and are all currently due.All notes are convertible to common shares, $0.001 par value, at a conversion price equal to the average bid price of the
common stock for the five trading days immediately preceding the conversion date. The notes are convertible when the Company’s
securities are trading publicly and the underlying stock of the debenture has been registered with the SEC and declared effective.
It is mandatory that the notes be converted on the sixth and seventh year of their anniversary date or are due and payable in
the event that the Company’s shares of common stock are not publicly traded.



Interest
expense for the six months ended June 30, 2011 and 2010 was $18,768 and $18,768, respectively. Interest expense for the three
months ended June 30, 2011 and 2010 was $9,384 and $9,384 respectively.



NOTE
9. STOCKHOLDERS’ EQUITY



In
June 2011, the Company issued 300,000 shares of common stock for marketing services. The fair market value of the stock on the
day of issuance was $13,500.



Options:



There
were no options granted during the six month period ended June 30, 2011.



Common
stock purchase options and warrants consisted of the following at June 30, 2011:





|                                               |           |              |      | Weighted Average |   | Aggregated
|---------------------------------------------- | --------- | ------------ | ---- | ---------------- | - | ----------
|                                               |           |              |      | Exercise         |   | Intrinsic 
|                                               |           | #
    shares |      | Price            |   | Value     
|Options:                                       |           |              |      |                  |  
|Outstanding and exercisable, December 31, 2010 | -         |              | N/A  | $                | -
|                                               | Granted   | -            |      |                  |   | -         
|                                               | Exercised | -            |      |                  |   | -         
|                                               | Expired   | -            |      |                  |   | -         
|Outstanding and exercisable, June 30, 2011     | -         |              | N/A  | $                | -
|                                               |           |              |      |                  |   |           
|Warrants:                                      |           |              |      |                  |  
|Outstanding and exercisable, December 31, 2010 | -         |              | N/A  | $                | -
|                                               | Granted   | 1,750,000    | $    | 0.10             |   | -         
|                                               | Exercised | -            |      |                  |   | -         
|                                               | Expired   | -            |      |                  |   | -         
|Outstanding and exercisable, June 30, 2011     | 1,750,000 | $            | 0.10 | $                | -





12









GLOBAL
HEALTH VOYAGER, INC. AND SUBSIDIARIES

(A
DEVELOPMENT STAGE COMPANY)

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

June
30, 2011 and 2010 (unaudited) and December 31, 2010







NOTE
11. LITIGATION



The
Company is subject to various claims covering a wide range of matters that arise in the ordinary course of its business activities.
Management believes that any liability that may ultimately result from the resolution of these matters will not have a material
adverse effect on the financial condition or results of operations of the Company.



During
2002, the Company's subsidiary, eCast, settled a lawsuit with its prior landlord of $100,000. As of June 30, 2011 the balance
due for the settlement had not been paid and is reflected as a current liability.

Management
is aware of a threatened litigation matter involving the nonpayment of approximately $9,000 in legal fees. Management is not aware
of any attempts by the claimant to pursue the litigation.

On November 1, 2010 the accounting firm of A.J. Robbins, P.C. filed a lawsuit in the District Court, City
and County of Denver, Colorado, seeking recovery of fees allegedly owed for accounting services performed during 2004 to 2008.
The claims have been asserted against the Company, a second corporate defendant, and our CEO, as a result of a personal guarantee.
On December 15, 2010, Defendants filed an Answer which asserted several defenses. The parties have exchanged initial disclosures,
and the matter has been set for trial commencing on December 5, 2011. On August 3, 2011 the parties entered into a settlement agreement
whereby the Defendants in the case will jointly pay $85,000 to the plaintiffs.  The payments will be made in equal monthly
payments over 7 months commencing on August 31, 2011.  In consideration of the settlement, the parties have executed a mutual
release and have agreed to withdraw the lawsuit. The releases and withdrawal are contingent upon the Company's full performance
of the settlement agreement terms. As of June 30 2011, the Company has recorded an accrual reflecting the settlement.











NOTE
12. SUBSEQUENT EVENTS



On
July 11, 2011, the Company entered into a facilitating agreement with AmeriMed Hospitals of Mexico. Through this agreement, the
Company plans to offer its users access to all of its hospital chains exotic destinations in Mexico. AmeriMed Hospitals has been
a leading health care provider in the market by taking care of more than 60,000 international patients at its hospitals located
in Los Cabos San Lucas, Cancun, Puerto Vallarta, and San Jose del Cabo.



On
July 26, 2011, the Company entered into a facilitating agreement with Med-International of Israel. Med-International is an Israeli-based
medical facilitator specializing in providing surrogacy and In Vitro Fertilization (IVF) treatments in Israel and Ukraine. The
Company plans to extend these specialties to its users through this arrangement







13









ITEM
2.          MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS



Forward-Looking
Statements



THIS
QUARTERLY REPORT ON FORM 10-Q, INCLUDING THE FOLLOWING MANAGEMENT'S DISCUSSION AND ANALYSIS, AND OTHER REPORTS FILED BY THE REGISTRANT
FROM TIME TO TIME WITH THE SECURITIES AND EXCHANGE COMMISSION (COLLECTIVELY THE "FILINGS"), CONTAIN FORWARD-LOOKING
STATEMENTS WHICH ARE INTENDED TO CONVEY OUR EXPECTATIONS OR PREDICTIONS REGARDING THE OCCURRENCE OF POSSIBLE FUTURE EVENTS OR
THE EXISTENCE OF TRENDS AND FACTORS THAT MAY IMPACT OUR FUTURE PLANS AND OPERATING RESULTS. THESE FORWARD-LOOKING STATEMENTS ARE
DERIVED, IN PART, FROM VARIOUS ASSUMPTIONS AND ANALYSIS WE HAVE MADE IN THE CONTEXT OF OUR CURRENT BUSINESS PLAN AND INFORMATION
CURRENTLY AVAILABLE TO US AND IN LIGHT OF OUR EXPERIENCE AND PERCEPTIONS OF HISTORICAL TRENDS, CURRENT CONDITIONS AND EXPECTED
FUTURE DEVELOPMENTS AND OTHER FACTORS WE BELIEVE TO BE APPROPRIATE IN THE CIRCUMSTANCES. YOU CAN GENERALLY IDENTIFY FORWARD-LOOKING
STATEMENTS THROUGH WORDS AND PHRASES SUCH AS "SEEK", "ANTICIPATE", "BELIEVE", "ESTIMATE",
"EXPECT", "INTEND", "PLAN", "BUDGET", "PROJECT", "MAY BE", "MAY
CONTINUE", "MAY LIKELY RESULT", AND SIMILAR EXPRESSIONS. WHEN READING ANY FORWARD-LOOKING STATEMENT YOU SHOULD
REMAIN MINDFUL THAT ALL FORWARD-LOOKING STATEMENTS ARE INHERENTLY UNCERTAIN AS THEY ARE BASED ON CURRENT EXPECTATIONS AND ASSUMPTIONS
CONCERNING FUTURE EVENTS OR FUTURE PERFORMANCE OF OUR COMPANY, AND ARE SUBJECT TO RISKS, UNCERTAINTIES, ASSUMPTIONS AND OTHER
FACTORS RELATING TO OUR INDUSTRY AND RESULTS OF OPERATIONS.



EACH
FORWARD-LOOKING STATEMENT SHOULD BE READ IN CONTEXT WITH, AND WITH AN UNDERSTANDING OF, THE VARIOUS OTHER DISCLOSURES CONCERNING
OUR COMPANY AND OUR BUSINESS MADE IN OUR FILINGS. YOU SHOULD NOT PLACE UNDUE RELIANCE ON ANY FORWARD-LOOKING STATEMENT AS A PREDICTION
OF ACTUAL RESULTS OR DEVELOPMENTS. WE ARE NOT OBLIGATED TO UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENT CONTAINED IN THIS REPORT
TO REFLECT NEW EVENTS OR CIRCUMSTANCES UNLESS AND TO THE EXTENT REQUIRED BY APPLICABLE LAW.



Overview



On
August 10, 2011, NT Media Corp. of California, Inc. changed its name to Global Health Voyager, Inc. (the "Company").
The Company is a Delaware corporation incorporated on March 14, 2000. The Company was focused on development, production and distribution
of programming in the entertainment industry including creating music platforms and skilled gaming in the US and abroad and vertical
social and professional networks. The Company discontinued developing media and entertainment assets and channels. In addition,
the Company completed phasing out several websites these past two quarters, which it had developed over the past several years
including www.neurotrash.tv, www.singlefathernetwork.com, and www.stemcellstalk.com.
Because these websites have not generated the advertisement revenues forecasted, the Company phased them out as it has shifted
its focus to developments in the Company’s recently launched medical tourism web portal.



On
November 1, 2010, the Company's Board of Directors (“BOD”) and management decided to change the focus of its business
from entertainment and website development to websites dedicated to the facilitation of medical tourism. The Company believes
that due to the potential high growth in the medical tourism industry, it is a better use of the Company's resources. The
Company has discontinued operations and maintenance of web destinations that it launched in the last several years, as it has
transitioned operations toward the development of one or more medical tourism websites.



On
April 20, 2011, the Company launched its initial medical tourism website called www.globalhealthvoyager.com. The website
is designed to be an information portal for users to facilitate medical procedures, hospitals, and clinics overseas. The website
is constantly being updated and will continue to be enhanced over time.



New
Company Focus



The
Company decided to redirect its focus on the medical tourism industry which it believes has high growth potential with minimal
upfront web portal development costs. The Company has recognized a unique opportunity to utilize its core competencies in web
development in the emerging medical tourism market. The Company’s new vision is to be a premier global healthcare facilitator
via the development of a web portal for resources in the medical tourism industry. The Company’s new mission is to facilitate
exceptional health care and services by highly qualified surgeons and advanced state-of-the-art facilities outside of the US for
a fraction of the cost of traditional healthcare in the US and other developed nations by providing individuals the opportunity
to research and connect with the providers of services abroad outside of their country of residence. The Company’s sole
employee is its president and he will continue his role as such. The Company plans to hire outside consultants and contractors
in the initial phases of the business transition to develop the Company's websites, partnerships and content with respect to all
aspects of non-US medical services, transportation and regulations. The Company will seek financing for the new venture through
private placements of equity and the issuance of debt securities to private investors. There can be no assurance that the Company
will successfully transition its business operations, attract or retain new personnel or obtain financing on terms satisfactory
to the Company, if at all.





14









The
Company’s core competencies in web developing, marketing, and social networking will allow it to cost effectively provide
information about world-class healthcare services via its medical tourism website which was launched in the second quarter of
2011.



The Company’s
reasons for focusing on this new business are as follows:



|- | Anticipated growth rate of medical tourism industry
|- | ---------------------------------------------------



|- | Low overhead
|- | ------------



|- | Emerging healthcare reform in the US
|- | ------------------------------------



|- | Fragmented businesses currently in the industry
|- | -----------------------------------------------



|- | Rising US healthcare costs
|- | --------------------------



|- | Growing uninsured and under-insured demographic in the US
|- | ---------------------------------------------------------



|- | International accreditation standardizing healthcare
|- | ----------------------------------------------------



|- | Long waiting periods for procedures in developed countries
|- | ----------------------------------------------------------



|- | Lower cost for procedures in exotic locations with the added bonus
    of a vacation during rehabilitation
|- | ----------------------------------------------------------------------------------------------------------



Medical
Tourism Industry



According
to the Deloitte Center for Health Solutions (“DCHS”), there are many factors contributing to the evolution of the
medical tourism industry. The first, and most significant, is the high price of medical procedures in the US. In many Western
European countries, the affluent often desire to have medical procedures without waiting. The US, particularly, will be responsible
for a large portion of the medical tourism industry as millions of Americans are either uninsured or under-insured. Costs for
procedures abroad are often less than the insurance co-payments in the US, sometimes significantly so. American insurance companies
have noticed this, and have begun to explore partnerships with doctors and hospitals overseas to take advantage of the price disparity.



One
of the most significant events leading to the growth of the medical tourism industry involves international accreditation. As
the number of state-of-the-art medical facilities has grown across the globe, the need to classify those with superior skills,
safety and training has become manifest, and a number of organizations have emerged to help potential patients and tourism agencies
discover which hospitals have standards that are similar, and in some cases superior, to those in the US.



In
addition to cost savings, there is another significant motivation for medical tourism. Given the stringent and often politically
motivated hurdles preventing certain procedures from being conducted in the US and Western Europe, such as stem cell therapy,
at times patients' only viable option is medical travel.



Medical
tourism is experiencing growth in the US and abroad driven by disparity in cost for required and elective surgical and other medical
treatments and procedures within and outside of the US. The Medical Tourism Association reported that several million Americans
traveled abroad for medical care in 2009 and the DCHS projects that outbound medical tourism could reach 1.6 million patients
by 2012, with sustainable annual growth of 35 percent. The Company intends to capitalize on the growth in this industry through
the development of our web-based platform and by developing relationships with hospitals and health care providers worldwide.
We believe the website planned by the Company will make it easy for patients to navigate and obtain information regarding healthcare
services performed worldwide.



New
Company Strategy



The
Company’s goal is to utilize its expertise in web development and marketing to create its own platform that will assist
patients in finding suitable international healthcare providers that meet their needs. The Company has plans to grow organically
by partnering with leading hospitals and facilitators in the medical tourism industry. The Company has developed a platform that
will increase customer awareness of medical tourism, and offers a broad and complete resource for those seeking medical treatments
abroad. There can be no assurance that the Company will successfully enter into partnerships with industry leaders.





15









The
Company completed its first milestone by launching a dedicated medical tourism website called www.globalhealthvoyager.com.
The Company is continuing establishing affiliations with internationally accredited hospitals and medical tourism facilitators.
The website is intended to inform potential patients of and attract them to international hospitals’ and facilitators’
healthcare services, if such affiliations develop. The Company will initially promote the website utilizing its existing marketing
base and plans to increase its marketing efforts as funding increases.



Partnerships
& Agreements



Management
is continuing to develop relationships with some of the top hospitals and medical facilities around the world, and intends to
provide information concerning health care providers in multiple geographic locations. There can be no assurance that the Company
will successfully create partnerships in any geographic location including the US. There can be no assurance that the Company
will develop affiliations with hospitals or will attract or provide services to consumers of medical services.



On
November 2, 2010, the Company entered into a facilitating agreement with the Apollo Hospital Group (“Apollo”). Through
the agreement, the Company plans to offer all of Apollo’s services to its users, which includes over 95 surgical specialties
and 8500 beds across 53 hospitals within and outside of India. Apollo is one of the largest healthcare groups in Asia.



On
November 10, 2010, the Company entered into a facilitating agreement with Hospital Clinica Biblica of Costa Rica (“HCB”).
Through this agreement, the Company plans to offer all of HCB’s specialty procedures to its users. The hospital has developed
an area of specialized services in more than 40 specialties and their respective sub-specialties in areas such as Chronic Cerebro-Spinal
Venous Insufficiency (“CCSVI”) liberation therapy for patients with Multiple Sclerosis make it one of the leading
institutions in Costa Rica.



On
November 15, 2010, the Company entered into a facilitating agreement with Assaf Harofeh Medical Center of Israel. Through this
agreement, the Company plans to offer all of the hospital’s advanced surgical procedures to its users. The hospital specializes
in areas such as in-vitro fertilization therapy and cancer treatments/therapies, which will be accessible to the Company’s
users.



On
April 20, 2011, the Company launched its initial medical tourism website called www.globalhealthvoyager.com.
The website is designed to be an information portal for users to facilitate medical procedures, hospitals, and clinics overseas.
The website is constantly being updated and will continue to be enhanced over time.



On
June 8, 2011, the Company entered into a consulting agreement with CPR Strategic Marketing Communication (“CPR”).
CPRdevelops and implements integrated business-to-business, business-to-professional and direct-to-consumer positioning
campaigns that drive market awareness. The Company plans to utilize CPR’s extensive network,
knowledge, and expertise within the medical tourism industry to successfully achieve its expansion strategy.



On
June 8, 2011, the Company entered into a “Global Healthcare Mobility Partner Program” agreement with Deutsche Lufthansa
AG of Germany. Through this agreement, the Company was able to establish up to a 20% discount on airfares for its users using
Lufthansa Airlines. Lufthansa is a member of the Star Alliance network, which is the leading global airline network, with the
highest number of member airlines, daily flights, destinations and countries.



Recent
Events



Since
the Company’s change in focus toward medical tourism, the Company has participated in many industry events, adding value
and opportunity toward accomplishing its vision. The Company has attended a number of conferences and seminars regarding medical
tourism and has established great relationships with hospitals, clinics, insurance providers, travel agents, and other facilitators.



On
April 27, 2011, representatives of the Company attended the European Medical Travel Conference in Barcelona, Spain.Every
year the European Medical Travel Conference is held in an EU member country, bringing together the international community of
the medical travel industry and the political representatives of various health care systems and policies. The
Company has successfully developed relationships and established agreements from attending the conference including such companies
as CPR and Lufthansa. The Company plans to attend a number of conferences and seminars within the industry, where it plans to
continue to develop successful relationships.



On
July 11, 2011, the Company entered into a facilitating agreement with AmeriMed Hospitals of Mexico. Through this agreement, the
Company plans to offer its users accesses to all of its hospital chains exotic destinations in Mexico. AmeriMed Hospitals has
been a leading health care provider in the market by taking care of more than 60,000 international patients to its hospitals located
in Los Cabos San Lucas, Cancun, Puerto Vallarta, and San Jose del Cabo.



On
July 26, 2011, the Company entered into a facilitating agreement with Med-International of Israel. Med-International is an Israeli-based
medical facilitator specializing in providing surrogacy and In Vitro Fertilization (“IVF”) treatments in Israel and
Ukraine. The Company plans to extend these specialties to its users through this arrangement.





16









The
Company plans to continue establishing and growing its network of hospitals, clinics, insurance providers, travel agencies, and
other facilitators within the medical tourism industry as it continues to develop its website.



Financing



Obtaining
outside financing will continue to be necessary to meet the Company’s anticipated working capital needs for the foreseeable
future. Given the Company’s current financial position, for the immediate future, we expect to operate the Company’s
current lines of business under strict budgetary constraints in order to keep operating expenses as low as possible. We will attempt
to negotiate extensions of the Company’s debt obligations or negotiate for the conversion of some or all of the Company’s
debt into equity; however, there can be no assurance that we will be successful.



In
June of 2011, the Company issued and sold convertible promissory notes and common stock purchase warrants for $350,000. See Part
II Item 2 and the financial statements in Part I Item1 for further details on this financing transaction.



Results
of Operations



OPERATING
RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2011 COMPARED TO THE SIX MONTHS ENDED JUNE 30, 2010



Operating
expenses decreased to $225,518 for the six months ended June 30, 2011 compared to $310,567 for the six months ended June 30, 2010
primarily due to a decrease in marketing expenses.



Other
expenses, consisting of interest, for the six months ended June 30, 2011 increased by $16,918 compared to the six months ended
June 30, 2010, primarily due to higher interest expense resulting from increases in notes payable.



Net
loss for the six months ended June 30, 2011 was $324,290, a decrease of $68,132, primarily due to the decrease in marketing expenses
as discussed above.





OPERATING
RESULTS FOR THE THREE MONTHS ENDED JUNE 30, 2011 AND COMPARED TO THE  THREE MONTH ENDED JUNE 30, 2010



Operating
expenses decreased to $130,189 for the three months ended June 30, 2011 compared to $209,159 for the three months ended June 30,
2010 primarily due to a reduction in expenses recognized under consulting and employment agreements.



Other
expenses, consisting of interest, for the three months ended June 30, 2011 increased by $9,187 compared to the three months ended
June 30, 2010 primarily due to higher interest expense resulting from increases in notes payable.



Net
loss for the three months ended June 30, 2011 was $181,229 a decrease of $69,783 compared to the net loss of $251,012 for the
three months ended June 30, 2010 mainly due to a net of decreased consulting and employment agreements and an increase in interest
expense as discussed above.



Off-Balance
Sheet Arrangements



We
have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect
on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures,
or capital resources, and that would be considered material to investors.





Liquidity
and Capital Resources



We
have incurred operating losses since inception. As of June 30, 2011, we have an accumulated deficit of $8,298,716.  At
June 30, 2011, we have $325,941 in cash and equivalents and a net working capital deficit of $4,511,849.



During
the last two years, the Company and its wholly owned subsidiary, eCast Media Corporation, Inc. (“eCast”), were dependent
on borrowed or invested funds to finance their ongoing operations.  As of June 30, 2011, eCast owed $620,000 for 6%
convertible notes and the Company owed $287,800 for 6% convertible notes. These notes were issued to two of the Company’s
major stockholders. These notes are classified as current liabilities.  We anticipate we will continue borrowing funds
or obtaining additional equity financing to provide working capital. We do not have sufficient cash on hand or from operations
to support the Company's operations for the next twelve months.



The
audit report of the Company’s independent registered public accounting firm for the year ended December 31, 2010, included
in the Company’s Annual Report on Form 10-K for the year then ended, includes a “going concern” explanation.
In the auditor’s opinion, the Company’s limited operating history and accumulated deficit as of December 31, 2010,
raised substantial doubt about the Company’s ability to continue as a going concern. We require approximately $4.85 million
over the next twelve months to pay off accounts payable and accrued expenses, and the convertible notes and notes payable reaching
maturity unless we obtain additional extensions.





17









Due
to our limited cash flow, operating losses and intangible assets, it is unlikely we could obtain financing through commercial
or banking sources. Consequently, we are dependent on continuous cash infusions from our major stockholders and other outside
sources to fund our current operations. If these outside sources are unwilling or unable to provide necessary working capital
to us, we will probably not be able to sustain operations. We have no written agreements or contractual obligations in place which
require our outside sources to continue to finance our operations. The Company's and eCast's convertible notes of $907,800 are
voluntarily convertible when the Company's or eCast's securities (as the case may be) are trading publicly and the underlying
stock of the convertible notes has been registered with the SEC on a registration statement that has been declared effective.
If they remain unpaid, the notes will automatically convert to Common Stock on the fifth anniversary of their respective issuances.  Thus,
$907,800 of current convertible notes would be mandatorily converted during 2011 unless they become eligible for conversion prior
to that time, or have been extended by the parties.In addition,
the Company has issued $350,000 of notesthat are convertible into Common Stock at the lower of (i) $0.10 or (ii) eighty
percent (80%) of the average closing bid price of the Common Stock during the 5 trading days preceding the date that a conversion
notice is delivered to the Company. The notes accrue interest at 10% and mature in June, 2014.



If
adequate funds do not become available, management believes its officers and directors will contribute capital amounts necessary
to fund the Company’s ongoing expenses; however, the Company’s officers and directors are under no obligation to do
so.  If we are unable to pay the Company’s debt as it becomes due and are unable to obtain financing on terms
acceptable to us, or at all, we will not be able to accomplish any or all of the Company’s initiatives and will be forced
to consider steps that would protect the Company’s assets against creditors.



Critical
Accounting Policies



There
were no critical accounting policies that by the nature of the estimates or assumptions are material due to the levels of subjectivity
and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change.



ITEM
3.          QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK



As a Smaller
Reporting Company, the Company is not required to respond to this Item 3.



ITEM
4.        CONTROLS AND PROCEDURES



Disclosure
Controls and Procedures



Under
the supervision and with the participation of our management, including our Chief Executive Officer and Acting Chief Financial
Officer (the “Certifying Officer”), we evaluated the effectiveness of the design and operation of our disclosure controls
and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act"))
as of the end of the period covered by this report. Based upon that evaluation, our Certifying Officer concluded that our disclosure
controls and procedures were not effective such that the information required to be disclosed by us in reports filed under the
Exchange Act is (a) recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms
and (b) accumulated and communicated to our management, including our chief executive officer, as appropriate to allow timely
decisions regarding disclosure.



Changes
In Internal Control Over Financial Reporting



There
were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange
Act) during the quarter ended June 30, 2011 that have materially affected, or are reasonably likely to materially affect, our
internal control over financial reporting.



Additional
Disclosure Concerning Controls and Procedures



We
currently believe the Company has material weaknesses in its disclosure controls and procedures. We will continue to work in the
coming months to address such weaknesses. We believe that the out-of-pocket costs, the diversion of management's attention from
running the day-to-day operations and operational changes caused by the need to make changes in our internal control and procedures
(as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) could be significant and still we may not achieve significant
improvements in our internal controls and procedures. If the time and costs associated with such compliance exceed our current
expectations, our results of operations and the accuracy and timeliness of the filing of our annual and periodic reports may be
materially adversely affected and could cause investors to lose confidence in our reported financial information, which could
have a negative effect on the trading price of our Common Stock.





18









PART
II

OTHER INFORMATION



ITEM
1.          LEGAL PROCEEDINGS



In
the normal course of business, we may become involved in various legal proceedings. Except as stated below, there are no other
past, pending or, to our knowledge, threatened litigation or administrative actions which in our opinion have had or are expected
to have a material adverse effect upon our business, prospects, financial condition or operations.



We
are aware of a threatened litigation matter involving the nonpayment of certain legal fees.  The claim for this matter
is approximately $9,000.



On November 1, 2010 the accounting firm of A.J. Robbins, P.C. filed a lawsuit in the District Court, City
and County of Denver, Colorado, seeking recovery of fees allegedly owed for accounting services performed during 2004 to 2008.
The claims have been asserted against the Company, a second corporate defendant, and our CEO, as a result of a personal guarantee.
On December 15, 2010, Defendants filed an Answer which asserted several defenses. The parties have exchanged initial disclosures,
and the matter has been set for trial commencing on December 5, 2011. On August 3, 2011 the parties entered into a settlement agreement
whereby the Defendants in the case will jointly pay $85,000 to the plaintiffs.  The payments will be made in equal monthly
payments over 7 months commencing on August 31, 2011.  In consideration of the settlement, the parties have executed a mutual
release and have agreed to withdraw the lawsuit. The releases and withdrawal are contingent upon the Company's full performance
of the settlement agreement terms. As of June 30 2011, the Company has recorded an accrual reflecting the settlement.





ITEM
1A.        RISK FACTORS



As a Smaller
Reporting Company, the Company is not required to respond to this Item 1A.



ITEM
2.          UNREGISTERED SALES OF EQUITY SECURITIES



During
the period covered by this Report, the Company issued and sold the following unregistered securities. The Company did not employ
any form of general solicitation or advertising in connection with the offer and sale of the Notes and Warrants (each as defined
below). In addition, the Company believes the investors are all “accredited investors” as defined in Rule 501(a) of
the Securities Act of 1933, as amended (the "Securities Act"). For these reasons, among others, the offer and sale of
the Notes and Warrants were made in reliance on the exemption from registration provided by Section 4(2) of the Securities Act
or Regulation D promulgated by the Securities and Exchange Commission (the “SEC”) under the Securities Act. The proceeds
of the sale of the Securities will be used by the Company for general working capital purposes.



On
July 28, 2011, the Company entered into two Amended and Restated Subscription Agreements (the "Agreements") with two
accredited investors pursuant to which the Company issued and sold (i) convertible promissory notes ("Notes") in the
aggregate principal amount of $350,000, and (ii) warrants (the "Warrants") to purchase an aggregate of 1,750,000 shares
of the Company's common stock (the "Common Stock"). The Agreements amended and restated certain Subscription Agreements
entered into by and between the Company and the investors in June of 2011. The Company received the investment proceeds in June
of 2011.

The
Notes are convertible into Common Stock at a price per share equal to the lower of (i) $0.10 or (ii) eighty percent (80%) of the
average closing bid price of the Common Stock during the 5 trading days preceding the date that a conversion notice is delivered
to the Company. The Notes accrue interest at a rate of 10% per annum and have a maturity date that is three years following the
date of issuance. The Warrants are exercisable for Common Stock at a price per share of $0.10. The Warrants expire three years
following the date of issuance. Neither the Notes nor the Warrants contain any anti-dilution or price adjustment protection. There
were no registration rights granted with respect to the Notes or Warrants. The Warrants do not contain a "cashless"
or "net exercise" feature. The Notes and Warrants contain "blocker" provisions which prohibit the investors
from obtaining ownership in excess of 4.99% of the Company's Common Stock. As of June 30, 2011, the Company has recorded an accrual
reflecting the settlement.



If
(i) the Warrants were fully exercised and (ii) the Notes were fully converted at an assumed conversion price of $0.08, the Company
would be required to issue 1,750,000 shares upon exercise of the Warrants and 4,375,000 shares upon conversion of the Notes for
a total of 6,125,000 shares of Common Stock.





19







ITEM
3.          DEFAULTS UPON SENIOR SECURITIES



None.



ITEM
4.          REMOVED AND RESERVED



ITEM
5.          OTHER INFORMATION



Effective
August 10, 2011, the Registrant changed its name to "Global Health Voyager, Inc." from "NT Media Corp. of California,
Inc." The Registrant's Common Stock is now listed on the Over the Counter Bulletin Board under the symbol "GLHV".
The symbol change was effective on August 10, 2011.

The
name change was effected through the merger of the Registrant with its wholly-owned Delaware subsidiary (Global Health Voyager,
Inc.) and as a result of the merger the Registrant's Certificate of Incorporation was amended to change its name to "Global
Health Voyager, Inc." The Registrant survived the transaction with the name of the subsidiary. The merger was effected pursuant
to Section 253 of the General Corporation Law of the State of Delaware. The merger was effective on August 10, 2011. A Certificate
of Ownership and Merger was filed with the Secretary of the State of the State of Delaware which became effective on August 10,
2011.



ITEM
6.          EXHIBITS



|Exhibit Number |     | Description                                                                                                               
|-------------- | --- | --------------------------------------------------------------------------------------------------------------------------
|3.1            | (1) | Certificate of Incorporation dated March 14, 2000                                                                         
|3.1.1          | *   | Certificate of Incorporation including Certificate of Ownership
    and Merger dated August 4, 2011                       
|3.2            | (1) | Bylaws dated March 14, 2000                                                                                               
|3.3            | (2) | Amendment to Certificate of Incorporation dated
    April 24, 2001                                                        
|3.4            | (3) | Certificate of Amendment of Certificate of Incorporation dated
    July 18, 2007                                          
|4.1            | (4) | 2009 Equity Incentive Plan dated March 6, 2009                                                                            
|4.2            | (5) | Form of Common Stock Purchase Warrant                                                                                     
|10.1           | (5) | Form of Subscription Agreement                                                                                            
|10.1           | (5) | Form of Convertible Promissory Note                                                                                       
|10.2           | *   | Agreement with Deutsche Lufthansa AG                                                                                      
|10.3           | *   | Facilitating agreement with AmeriMed Hospitals of Mexico                                                                  
|10.4           | *   | Facilitating agreement with Med-International of Israel                                                                   
|31             | *   | Certification Pursuant to Section 302 of the Sarbanes-Oxley Act
    of 2002                                               
|32             | *   | Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant
    to Section 906 of the Sarbanes-Oxley Act of 2002

* 	Filed
herewith.

(1)	Filed
as an exhibit to the Company’s Registration Statement (File No. 333-38322), Amendment No. 1, on Form SB-2/A on August 23,
2000.

(2) 	Filed
as an exhibit to the Company’s Current Report on Form 8-K filed on May 1, 2001.

(3)	Filed
as an exhibit to the Company’s Current Report on Form 8-K filed on July 19, 2007.

(4)	Filed
as an exhibit to the Company’s Registration Statement (File No. 333-157748) on Form S-8 filed on March 6, 2009.

(5)	Filed
as an exhibit to the Company's Current Report on Form 8-K filed on August 3, 2011.





20









SIGNATURES



Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.



|                         | GLOBAL HEALTH VOYAGER, INC.
|------------------------ | ---------------------------
|                         |                            
|Dated:   August 15, 2011 |                            
|                         |                            
|                         |                            





21